John F. Milligan's Insider Trades & SAST Disclosures
John F. Milligan's most recent trade in Pacific Biosciences of California Inc was a trade of 32,179 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John F. Milligan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of Cal... | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 32,179 | 32,179 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 22,821 | 132,821 (0%) | 0% | 0 | Common Stock | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 26,791 | 26,791 | - | - | Stock Option (Right To Buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 33,750 | 33,750 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 33,750 | 33,750 | - | - | Stock Option (Right to Buy) | |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,885 | 12,885 | - | - | Stock Option (right to buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 11,250 | 11,250 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | John F. Milligan | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 15 Dec 2020 | 100,000 | 100,000 | - | 23 | 2,300,000 | Common Stock |
| Pacific Biosciences of Cal... | John F. Milligan | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.67 per share. | 24 Aug 2020 | 35,000 | 35,000 (0%) | 0% | 2.7 | 93,450 | Common Stock |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2020 | 35,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2020 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2020 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2020 | 25,000 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.61 per share. | 24 Aug 2020 | 25,000 | 110,000 (0%) | 0% | 2.6 | 65,250 | Common Stock |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.81 per share. | 24 Aug 2020 | 25,000 | 85,000 (0%) | 0% | 3.8 | 95,250 | Common Stock |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.45 per share. | 24 Aug 2020 | 25,000 | 60,000 (0%) | 0% | 4.5 | 111,250 | Common Stock |
| Pacific Biosciences of Cal... | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 97,785 | 97,785 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges